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Case Report

Vaccine-associated Feline Sarcoma (VAFS) with Multiple
Recurrences in a Turkish Van Cat
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Babür B‹L‹R
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Received: 19.02.2003

Abstract: Vaccine-associated feline sarcoma (VAFS) with multiple recurrences was diagnosed in the specimens at the injection site
of a Turkish Van cat that had been vaccinated four months previously. The original tumor consisted of two compartments each 2.5
cm and 3.5 cm in diameter. It recurred five times following surgery and local recurrences necessitated five more radical resections
within two years. Euthanasia was performed when pleural effusion developed, but evidence of metastatic disease was not observed.
This article reports the first case of a vaccine-associated feline sarcoma in a Turkish Van cat clinically diagnosed as prominent evidence
of postvaccinal sarcoma from Turkey with the biological aggressive features comparable with cases overseas.
Key Words: Vaccine-associated sarcoma, multiple recurrences, Van cat

Bir Van Kedisinin Afl› Enjeksiyon Yerinde Geliflen
Multiple Rekurrensli Sarkom Olgusu
Özet: Bu çal›flmada, dört ay önce afl›lanm›fl bir Van kedisinin afl› enjeksiyon yerinde geliflen multiple rekurrensli sarkom olgusu
tan›mland›. Orijinal tümör biri 2.5 ve di¤eri 3,5 cm çapl› olmak üzere iki ayr› lobluydu; iki y›l içinde befl kez nüks etti ve radikal
rezeksiyonlarla sa¤alt›lmaya çal›fl›ld›. ‹kinci y›l içinde geliflen plöyral efüzyon sonucu hayvan ötenazi edildi, ancak metastazlara
rastlanmad›.
Hayvan sahibinin verdi¤i anamnez bilgileri, klinik ve patolojik bulgular ile çeflitli ülkelerde tan›mlananlara büyük benzerli¤inden
hareketle, Türkiye’de bir Van kedisinde afl›lamaya ba¤l› yang›sal granulomun fibrosarkoma geliflmifl olabilece¤i düflünüldü.
Anahtar Sözcükler: Afl› iliflkili sarkom, multiple rekurrens, Van kedisi

Introduction
Since it was first indicated that injection site reactions
induce fibrosarcoma in cats by Hendrick and Goldschmidt
in 1991 (1), an increased incidence of soft tissue
sarcomas in areas routinely used by veterinarians for
vaccination in cats has been found in the United States of
America (2-7).
Most studies have been focused on the issue of
sarcoma formation associated with vaccination, its
epidemiology, risk factors, pathogenesis, etiology, and
treatment of the disease in cats (2-5,8,9). In response to
concerns about this emerging health issue of cats, the

Vaccine-Associated Feline Sarcoma Task Force (VAFSTF)
was formed in 1996 in the USA (10).
Some cases have also been recently reported in
Canada (11), Australia (12), and England (13) following
the report issued in the United States of America.
However, we are not aware of any reports that have
identified vaccination-associated feline sarcoma in our
country, although injection-site reactions after vaccination
are very well known by our veterinarians (observations of
the second author).
This article reports the first case of a vaccineassociated feline sarcoma seen in a Turkish Van cat from
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Turkey with a temporal association between vaccination
and sarcoma formation.

Case History
A four-year-old female Turkish Van cat was brought
to the Department of Surgery, Faculty of Veterinary
Medicine, University of Ankara, due to an ovoid
subcutaneous mass, measuring approximately 5 cm, on
the right dorsothoracal region.
According to the owner, the cat had been brought for
routine annual vaccinations 4 months prior to the
appearance of the mass. The vaccination had been
performed simultaneously in this area by combining
modified live feline viral rhinotracheitis / calicivirus /
panleukopenia virus (FVRCP) and inactivated adjuvanted
rabies vaccine. One month later, the animal was
developing a small, firm, nodulary mass at the site of
vaccination, and it had been returned with the diagnosis
of inflammatory granuloma. As a result, this granuloma
had begun increasing in size within the last month, with
a very large amount of growth during the last 15 days.

were principally very similar to each other, except for the
central cavitation (Figure 2). However, the larger mass
had a more uniform glistening white appearance with
hard woven areas whereas the smaller mass, which was
loosely woven, had a more mixed color appearance with
dull/gray and glistening/white areas as to be lined
randomly circular. Moreover, it was clearly observed that
the masses were partly separated both from one another
and from surrounding tissues with a peripheral boundary.
Histologically, the tumor tissues were consistent with
fibrosarcoma (larger mass) and malignant fibrous
histiocytoma of the giant-cell type (smaller mass). The

Results and Discussion
The conclusion of the physical examination of the cat
was negative except for the mass. Diagnostic biopsy was
performed and a diagnosis of fibrosarcoma was made
histologically. The tumor was later totally removed,
dissected from the surrounding tissue with elliptical
incision.
The tumor was macroscopically 4 x 6 x 3 cm, sharply
demarcated, round to ovoid, located within subcutis, and
consisted of adjoining two major lobulated masses
(Figure 1). Both masses were relatively well demarcated,
somewhat elastic in consistency, and had a few small
protuberances on their outer surface. The larger mass
also fluctuated in palpation. On the cut surface, the larger
mass (3 x 4 cm) appeared to have a central cavitation
containing a peripherally located white tumor tissue with
multifocal variably sized dark hemorrhagic areas. The
central cavitation was filled with viscous/gelatinous
grayish fluid. In contrast, the smaller mass (2.5 cm) did
not have a central cavitation and was thin lobulary and
separated by thin white and gray septa with small dark
colored areas. The appearances of the masses cut
surfaces, which were glistening grayish-white in color,
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Figure 1. Macroscopic appearance of the tumor consisted of adjoining
two major lobulated masses with a few small protuberances
on their outer surface.

Figure 2. The appearance of the cut surface of the tumor. Two major
masses are partly separated both from one another and
from surrounding tissues with a peripheral boundary. Note
the larger mass with a peripherally located white tumor
tissue containing a central cavitation (above) and the smaller
mass with thin lobulary and separated by thin white and
gray septa (bottom).
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larger mass had numerous spindle cells with marked
nuclear and cellular pleomorphism, high mitotic activity,
large central zone of necrosis, and peripheral
inflammatory infiltrate (Figure 3). In addition to these
findings, the smaller mass had numerous multinucleated
giant cells and variable numbers of pleomorphic poligonal
to histiocytoid cells with mild to marked atypia (Figure 4).
The majority of cells of the tumor tissue were
immunoreactive for both vimentin and alpha-smooth
muscle actin antibodies.
Two months later, the tumor recurred in the same
area and a larger excision of the first surgical excision was
performed. Results of the histopathologic examination
were similar to the findings of the first biopsy material.
As a result, it was presumed that this case was typical of
vaccination associated feline sarcoma, along with its
findings and aggressive biological features, such as
anaplasia, rapid growth and recurrency, extensive central
necrosis and prominent tumor giant cells, peripheral
inflammatory infiltrate, location and histologic
appearance in addition to known vaccination history.

After the first recurrence, the cat continued to be
observed in an effort to perform for early intervention.
Thus, the following four recurrences were treated
surgically as they occurred, in a special veterinary clinic by
the second author. As a result of inconvenience and with
the agreement of the owner, the cat was euthanized
when pleural effusion developed within the second year
of the first surgery. However, complete necropsy was not
performed as the owner refused.
Over the past decade, there have been various reports
of soft tissue tumors in cats at typical vaccination sites,
referred to as vaccine-associated feline fibrosarcomas
(VAFSs) in the United States of America (3,4,14). It has
been suggested that the vaccine industry has shifted from
production of modified-live virus vaccines to killed-virus
vaccines and that the vaccination site has shifted from
intramuscular to subcutaneous routes of injection,
previously an uncommon form of injection (1). Also, it
has been found that the risk of the development of VAFS
increases with the number of vaccines given at the same
time (3).

Results of thoracic radiography were negative for
tumor metastasis at that time.

The cat of the present study was vaccinated
subcutaneously by inactivated adjuvanted rabies and
modified live FVRCP vaccines on same date, into the same

Figure 3. Microscopic appearance of the larger tumor nodule. Note
large aggregates of lymphocytes along the periphery of the
tumor tissue. HE x200.

Figure 4. Microscopic appearance of the smaller tumor nodule.
Numerous multi-nucleated giant cells are interspersed with
spindle cells showing marked nuclear and cellular
pleomorphism. HE x400.
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area with injection sites in close proximity. It may be
speculated that VAFS was produced within a few months
via subcutaneous injection of both vaccines or one of
them. With the most optimistic consideration, this animal
could also be genetically predisposed to tumor
development after trauma due to injection, regardless of
differences in vaccine types.
It has been considered that vaccination-associated
feline sarcomas, which are often larger and more
aggressive in their biological behavior, differ from
classical fibrosarcoma in younger animals, are highly
invasive and rapidly recur following attempted excisions
with margins that would be considered curative for most
normal fibrosarcomas (4,10,13). There is also a broad
spectrum of histologic types and unique histologic
characteristics when compared with classical
fibrosarcomas
unassociated
with
vaccination.
Histopathological assessment of the vaccine-associated
feline fibrosarcomas were often fibrosarcomas but many
other types of sarcomas also have been reported such as
rhabdomyosarcoma, chondrosarcoma, osteosarcoma,
myofibroblastic sarcoma, and malignant fibrous
histiocytoma by different pathologists (5-7,12,15). Also,
histopathological features of three tumor types have been
reported at the same injection site of a single patient
(16). However, there is not difference in prognosis to the
varying morphological forms of postvaccinal sarcomas.

The present case described is in accordance with above
findings.
In veterinary practice it is well known that injection of
some vaccines results in focal necrotizing granulomatous
panniculitis which progresses to sarcoma, sometimes in
cats (17). Likewise, clinical veterinarians in our country
have recognized for several years the development of
inflammatory granulomatous reactions at some
vaccination sites and have interpreted these inflammatory
nodules to represent adverse vaccination reactions
(observations of the second author). In the last three to
five years, soft tissue sarcomas were also more
commonly found by our clinics in the Ankara district in
Turkey (observations of the authors) in the
thoracal/interscapular regions of cats than in the
extremities or head. It is now also possible to see various
cats referred to small animal clinics in our country with
vaccination-associated feline sarcomas similar to oversea
clinics. A general awareness must be made that the
injection of some vaccines may result in inflammatory
granulomas in some cats. It is well known, but not
considered prominent, that some of these inflammatory
reactions progress to sarcomas. In the future, real causal,
prognostic and risk factors, pathogenesis and
pathological findings, etiology and epidemiology, and
treatment options relating to this disorder must be
determined.
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